https://mn64inhibitor.com/reco....rd-development-bottl
Patients with condition development despite RTX induction therapy had with greater regularity renal participation (67% versus 25%, p= 0.02) with renal failure (serum creatinine 100 µmol/l in 42per cent versus 8%, p= 0.02) in contrast to settings. After salvage therapy, remission had been attained at 6 months in 35 (69%) patients. Probably the most regular salvage therapy was changing from ivCYC to RTX (or the other way around), showing an efficacy in 21/29 (72%)
Curtir
Comentario
Compartilhar
